SCHEMBL1754864

SCHEMBL1754864

O=P(O)(O)CCN(c1cccc2ccccc12)S(=O)(=O)c1cc(Br)cc(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
KEAP1 Q14145 7/20 0.39
NFE2L2 Q16236 7/20 0.39
ESR1 P03372 5/20 0.36
ACP3 P15309 1/20 0.36
MEN1 O00255 1/20 0.35
PER2 O15055 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
CRY1 Q16526 1/20 0.35
CRY2 Q49AN0 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ACP1 P24666 1/20 0.33
MMP9 P14780 1/20 0.33
LMNA P02545 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3281102 0.92 KDM4E (0.39) KDM4EKEAP1NFE2L2ESR1ACP3
SCHEMBL2055478 0.88 KDM4E (0.44) KDM4EKEAP1NFE2L2ESR1ACP3
SCHEMBL2055491 0.81 KDM4E (0.40) KDM4EKEAP1NFE2L2ESR1ACP3
SCHEMBL2055489 0.81 KDM4E (0.40) KDM4EKEAP1NFE2L2ESR1ACP3
SCHEMBL1110282 0.80 KEAP1 (0.63) KEAP1NFE2L2
SCHEMBL1754865 0.77 HTR2C (0.36) KDM4EESR1ACP3MEN1PER2
SCHEMBL2055371 0.76 KDM4E (0.40) KDM4EKEAP1NFE2L2ESR1MEN1
SCHEMBL2101974 0.74 KDM4E (0.33) KDM4EKEAP1NFE2L2ESR1ACP3
SCHEMBL1754451 0.74 KDM4E (0.44) KDM4EKEAP1NFE2L2ACP3MEN1
SCHEMBL2055485 0.74 KDM4E (0.44) KDM4EKEAP1NFE2L2ACP3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2200987-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2010-06-30 EP claimed
WO-2009030715-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-12 WO claimed
EP-2200987-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2010-06-30 EP disclosed
WO-2009030715-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-12 WO disclosed